BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18977769)

  • 1. Anticoagulant mechanism of factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
    Ishikawa M; Kumashiro M; Yamazaki Y; Atoda H; Morita T
    J Biochem; 2009 Jan; 145(1):123-8. PubMed ID: 18977769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
    Atoda H; Yoshida N; Ishikawa M; Morita T
    Eur J Biochem; 1994 Sep; 224(2):703-8. PubMed ID: 7925387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of calcium(II) ions in the recognition of coagulation factors IX and X by IX/X-bp, an anticoagulant from snake venom.
    Sekiya F; Yamashita T; Morita T
    Biochemistry; 1995 Aug; 34(31):10043-7. PubMed ID: 7632677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel blood coagulation factor IX/factor X-binding protein with anticoagulant activity from the venom of Trimeresurus flavoviridis (Habu snake): isolation and characterization.
    Atoda H; Morita T
    J Biochem; 1989 Nov; 106(5):808-13. PubMed ID: 2613688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a venom factor devoid of proteolytic activity from Taiwan habu (Trimeresurus mucrosquamatus): N-terminal sequence homology and no functional similarity to factors IX/X-binding proteins and botrocetin.
    Chiou SH; Huang KF; Chow LP; Tsugita A; Wu SH
    J Protein Chem; 1996 Oct; 15(7):667-74. PubMed ID: 8968958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and functions of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
    Morita T; Atoda H; Sekiya F
    Adv Exp Med Biol; 1996; 391():187-96. PubMed ID: 8726056
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood coagulation factor IX-binding protein from the venom of Trimeresurus flavoviridis: purification and characterization.
    Atoda H; Ishikawa M; Yoshihara E; Sekiya F; Morita T
    J Biochem; 1995 Nov; 118(5):965-73. PubMed ID: 8749314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and sequence characterization of coagulation factor IX/factor X-binding protein from the venom of Echis carinatus leucogaster.
    Chen YL; Tsai IH
    Biochemistry; 1996 Apr; 35(16):5264-71. PubMed ID: 8611513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood coagulation factor IX/factor X-binding proteins with anticoagulant activity].
    Atoda H; Morita T
    Rinsho Byori; 1989 Apr; Spec No 81():75-81. PubMed ID: 2754813
    [No Abstract]   [Full Text] [Related]  

  • 10. cDNA cloning of IX/X-BP, a heterogeneous two-chain anticoagulant protein from snake venom.
    Matsuzaki R; Yoshiara E; Yamada M; Shima K; Atoda H; Morita T
    Biochem Biophys Res Commun; 1996 Mar; 220(2):382-7. PubMed ID: 8645314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation factor X inhibitor from hundred-pace snake (Deinagkistrodon acutus) venom.
    Cox AC
    Toxicon; 1993 Nov; 31(11):1445-57. PubMed ID: 8310445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycoprotein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fc epsilon receptor for immunoglobulin E.
    Atoda H; Hyuga M; Morita T
    J Biol Chem; 1991 Aug; 266(23):14903-11. PubMed ID: 1831197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrangement of the disulfide bridges in a blood coagulation factor IX/factor X-binding protein from the venom of Trimeresurus flavoviridis.
    Atoda H; Morita T
    J Biochem; 1993 Feb; 113(2):159-63. PubMed ID: 8468322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.
    Hertzberg MS; Ben-Tal O; Furie B; Furie BC
    J Biol Chem; 1992 Jul; 267(21):14759-66. PubMed ID: 1634519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of an anticoagulant protein homologous to botrocetin from the venom of Bothrops jararaca.
    Sekiya F; Atoda H; Morita T
    Biochemistry; 1993 Jul; 32(27):6892-7. PubMed ID: 8334120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pathway of coagulation on endothelial cells.
    Nawroth PP; Stern DM
    J Cell Biochem; 1985; 28(4):253-64. PubMed ID: 3877062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic procoagulant surface induced by hypercholesterolaemia on rabbit aortic endothelium.
    Lupu F; Moldovan N; Ryan J; Stern D; Simionescu N
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):743-52. PubMed ID: 8292724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
    Suzuki K
    Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved procedures for the purification of selected vitamin K-dependent proteins.
    Novoa E; Seegers WH; Hassouna HI
    Prep Biochem; 1976; 6(5):307-38. PubMed ID: 787972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.